ArticleTherapeutic advances in neurological disorders2024

The effects of treatment with pimavanserin on activities of daily living in patients with Parkinson's disease psychosis: a 16-week, single-arm, open-label study.

Virgilio G H Evidente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.